Moderna expecting Covid-19 booster by August, unsure on Omicron specific vaccine
The CEO of US biotech firm Moderna (MRNA.O) told Reuters that an Omicron-specific booster vaccine could be ready by August, but the company is still gathering clinical data to determine whether that vaccine would provide better protection than a new dose of...
17 February, 2022
Read more